Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript.

Name: Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript.
Author: Lucas, Claire M

Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript. — المؤلف: Lucas, Claire M — Haematologica 20110804

المؤلف: Lucas, Claire M
النشر: Haematologica 20110804
الوصف: 1362-7 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Benzamides؛ Female؛ Follow-Up Studies؛ Fusion Proteins, bcr-abl؛ Humans